-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Silexion To Begin Phase 2/3 Pancreatic Cancer Clinical Trial In Q2 2026

Reuters·11/25/2025 16:46:37

Please log in to view news